-
Faced with limited data about acute mountain sickness in children traveling rapidly to high altitude, Swiss researchers studied symptoms in 48 children (ages 10-17, mean age 13) who traveled 2 ½ hours from low altitude (568 meters) to 3450 meters (approximately 11,200 feet).
-
The risks for illness acquired during travel are greater in immunocompromised travelers.
-
n this issue: Drug combinations for hypertension; tenecteplase for out-of-hospital cardiac arrest; CAM most commonly used for back, neck, and arthritis pain; FDA Actions.
-
Many physicians have followed the historical practice of ordering blood cultures to be drawn as close as possible to the time of the peak of the febrile episode (fever spike).
-
In this issue: The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
-
At the 51st meeting of the American Society of Tropical Medicine and Hygiene in Denver, November 10-14, 2002, a full symposium was devoted to yellow fever.
-
Conference coverage: emerging infections and outbreaks, malaria, schistosomiasis, bacterial infections
-
The emergence of chronic wasting disease, a transmissible spongiform encephalopathy in North American cervids, raises concern about potential transmission to humans, as has occurred elsewhere with bovine spongiform encephalopathy and vCJD.
-
FDA Approves Generic Version of AstraZenecas Prilosec; Pegasys
Approved To Treat Hepatitis C; HRT Reduces Alzheimers Risk, Study
Says; Heparin Plus Alteplase More Effective; Digoxin Effects Differ By
Sex; McClellan Named FDA Commissioner; FDA Actions
-
An excellent update on rabies was provided by Charles E. Rupprecht, the Rabies Section Chief of the CDC, during the Symposium, Control of Zoonoses: A Veterinary Perspective at the recent 51st annual ASTMH meeting in Denver, Colo.
